<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01230294</url>
  </required_header>
  <id_info>
    <org_study_id>S275-2010</org_study_id>
    <nct_id>NCT01230294</nct_id>
  </id_info>
  <brief_title>New Echocardiographic Methods for Right Ventricular Function.</brief_title>
  <acronym>NEW-RV</acronym>
  <official_title>Evaluation of New Echocardiographic Methods for Measurement of Right Ventricular Function.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heidelberg University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heidelberg University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aims of this study are the evaluation of new echocardiographic methods (3D/4D- and
      strain-echocardiography) for measurement of the right ventricular (RV) function .
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Studies of the last years revealed that the right ventricular function is an important
      predictive value for the survival of patients with congenital heart disease, pulmonary
      hypertension or chronic heart failure. In 2006 the National Heart, Lung and Blood Institute
      has pronounced the right ventricular dysfunction including the non-invasive assessment of the
      right ventricular function as preferential aim of cardiovascular research.

      Many parameters are used to describe right ventricular dysfunction, but none of these has a
      comparable significance like the left ventricular ejection fraction. Because of the
      limitation of each right ventricular parameter the stepwise combination of these parameters
      is used to describe right ventricular function what frequently results in further problems,
      especially in comparison of long-term controls.

      Aims of this study are the evaluation of new echocardiographic methods (3D/4D- and
      strain-echocardiography) for measurement of the right ventricular (RV) function. The study is
      carried out as prospective, monocentric trial at the Department of Cardiology of the
      University Hospital of Heidelberg. Three different groups are set up for the assessment of
      the right ventricular function: patients with pulmonary arterial hypertension, patients with
      chronic heart failure of the left ventricle affecting the right heart and patients without
      structural heart disease who underwent an echocardiographic examination for other reasons
      (control group).

      All participants are re-examined in constant intervals as clinically indicated.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>October 2010</start_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>3D-volumetry of the right ventricle</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>2D strain of the right ventricle</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>pulmonary artery systolic pressure (PASP)</measure>
    <time_frame>2 years</time_frame>
    <description>standard value: ≤ 30 mmHg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>tricuspid annular plane systolic excursion (TAPSE)</measure>
    <time_frame>2 years</time_frame>
    <description>standard value: ≥ 20 mm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>tricuspid annular systolic velocity (TASV)</measure>
    <time_frame>2 years</time_frame>
    <description>standard value: ≥ 20cm/s</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tei-index (myocardial performance index)</measure>
    <time_frame>2 years</time_frame>
    <description>standard value: ≥ 0,5</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LV-eccentricity-index (Lei-index)</measure>
    <time_frame>2 years</time_frame>
    <description>standard value: ≥ 1,0</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Right Ventricular Dysfunction</condition>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <description>participants without structural heart disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CHF</arm_group_label>
    <description>patients with chronic heart failure of the left ventricle affecting the right heart</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PAH</arm_group_label>
    <description>patients with pulmonary arterial hypertension without left ventricular dysfunction</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        -  patients with pulmonary aterial hypertension

          -  patients with chronic heart failure of the left ventricle affecting the right heart

          -  patients without structural heart disease who underwent an echocardiographic
             examination for other reasons (control group)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  persons of 18 years and older who receive a transthoracic echocardiography at our
             department

          -  written consent

        Exclusion Criteria:

          -  present atrial fibrillation/flutter

          -  permanent pacemaker rhythm

          -  moderate/severe valvular heart disease

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sebastian Greiner, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heidelberg University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Derliz Mereles, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heidelberg University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <state>Baden-Wuerttemberg</state>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Greiner S, André F, Heimisch M, Hess A, Steen H, Katus HA, Mereles D. Non-invasive quantification of right ventricular systolic function by echocardiography: a new semi-automated approach. Clin Res Cardiol. 2013 Mar;102(3):229-35. doi: 10.1007/s00392-012-0528-z. Epub 2012 Dec 4.</citation>
    <PMID>23208080</PMID>
  </results_reference>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 28, 2010</study_first_submitted>
  <study_first_submitted_qc>October 28, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 29, 2010</study_first_posted>
  <last_update_submitted>November 5, 2016</last_update_submitted>
  <last_update_submitted_qc>November 5, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 8, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Heidelberg University</investigator_affiliation>
    <investigator_full_name>Derliz Mereles</investigator_full_name>
    <investigator_title>Derliz Mereles, M.D.</investigator_title>
  </responsible_party>
  <keyword>echocardiography of the right heart</keyword>
  <keyword>3D 4D echocardiography</keyword>
  <keyword>strain measurement</keyword>
  <keyword>chronic heart failure</keyword>
  <keyword>pulmonary hypertension</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ventricular Dysfunction</mesh_term>
    <mesh_term>Ventricular Dysfunction, Right</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

